What is the bioavailability of the inhaler?
Tudorza Pressair (Aclidinium)
Status:
Open Apr 23, 2025 - 03:58 PM
1answer
Answer
Apr 23, 2025 - 03:58 PM
The bioavailability of the inhaler is less than 5%. This low bioavailability ensures that the medication primarily acts in the lungs, minimizing systemic side effects.
View More Product Details
Tudorza Pressair (Aclidinium)
Tudorza Pressair is an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease.
Buy Now
View all Tudorza Pressair (Aclidinium) Questions & Answers